ArticleJournal of nanobiotechnology2026
Cascade catalytic nanozyme platform for combined antibacterial, anti-inflammatory, and pro-healing therapy of infected diabetic wounds.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The wounds of diabetic patients are prone to bacterial infection due to complex microenvironments. Improving the microenvironment of diabetic wounds and controlling bacterial infection are crucial for wound healing in diabetic patients. We constructed a cascade catalytic antibacterial agent (h-CuSe-PEG/GOx) by using the hollow copper selenide nanocubes (h-CuSe NCs) loaded with glucose oxidase (GOx). The sythesized h-CuSe NCs possess peroxidase-like (POD-like), glutathione peroxidase-like (GPx-like), and oxidase-like (OXD-like) activities. The loaded GOx can reduce the wound pH and generate H2O2 in situ, further enhancing the catalytic reactive oxygen species (ROS) generation. The h-CuSe-PEG/GOx exhibited efficient antimicrobial properties against Gram-negative Escherichia coli (E. coli), Gram-positive Staphylococcus aureus (S. aureus), as well as ampicillin-resistant Escherichia coli (MREC) and methicillin-resistant Staphylococcus aureus (MRSA). The results of in vivo experiments showed that h-CuSe-PEG/GOx reduced the expression of pro-inflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) by inhibiting bacterial growth, thereby alleviating the inflammatory response. At the same time, it enhanced the expression of cluster of differentiation 31 (CD31) and vascular endothelial growth factor (VEGF) and promoted angiogenesis. Therefore, the use of cascade catalytic nanozyme strategy can effectively control bacterial infection, improve wound microenvironment and promote wound healing, which is of clinical significance for the treatment of diabetic wounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.